ImmunoPET for prostate cancer in the PSMA era : do we need other targets?

Show simple item record

dc.contributor.author Filippi, Luca
dc.contributor.author Evangelista, Laura
dc.contributor.author Sathekge, Mike Machaba
dc.contributor.author Schillaci, Orazio
dc.date.accessioned 2023-06-09T07:02:04Z
dc.date.issued 2022-12
dc.description.abstract Please read abstract in the article. en_US
dc.description.department Nuclear Medicine en_US
dc.description.embargo 2023-08-21
dc.description.librarian hj2023 en_US
dc.description.uri https://link.springer.com/journal/40336 en_US
dc.identifier.citation Filippi, L., Evangelista, L., Sathekge, M.M. et al. ImmunoPET for prostate cancer in the PSMA era: do we need other targets? Clinical and Translational Imaging 10, 587–596 (2022). https://doi.org/10.1007/s40336-022-00520-w. en_US
dc.identifier.issn 2281-5872 (print)
dc.identifier.issn 2281-7565 (online)
dc.identifier.other 10.1007/s40336-022-00520-w
dc.identifier.uri http://hdl.handle.net/2263/91067
dc.language.iso en en_US
dc.publisher Springer en_US
dc.rights © The Author(s), under exclusive licence to Italian Association of Nuclear Medicine and Molecular Imaging 2022. The original publication is available at http://link.springer.com/journal/40336 [12 months embargo] en_US
dc.subject Prostate stem cell antigen (PSCA) en_US
dc.subject Metastatic castration-resistant PC (mCRPC) en_US
dc.subject Prostate specific membrane antigen (PSMA) en_US
dc.subject Prostate cancer en_US
dc.subject ImmunoPET en_US
dc.subject Precision medicine en_US
dc.subject Positron emission tomography/computed tomography (PET/CT) en_US
dc.subject Castration-resistant prostate cancer en_US
dc.subject Theranostics en_US
dc.subject SDG-03: Good health and well-being en_US
dc.title ImmunoPET for prostate cancer in the PSMA era : do we need other targets? en_US
dc.type Postprint Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record